West Pharmaceutical Services to Announce Q2 2026 Financial Results
West Pharmaceutical Services, Inc. will release its second-quarter 2026 financial results before the market opens on Thursday, July 23, 2026.
Exton, Pennsylvania – West Pharmaceutical Services, Inc. (NYSE: WST) announced on July 7, 2026, that it will release its second-quarter 2026 financial results before the market opens on Thursday, July 23.
In conjunction with the earnings release, the company will host a conference call for its portfolio managers and analysts. The call will provide details regarding an updated 2026 financial outlook.
The call is scheduled to begin at 9:00 AM Eastern Time. It will be hosted by West's management team, including Chief Executive Officer Brian D. Gallagher and Chief Financial Officer Vincent P. Mascione.
A webcast of the event will be available through West's Investor Relations website. A replay of the call will also be accessible on the website following the earnings announcement.